Mark Gardner is the Chief Executive Officer of OmniSeq Precision Medicine Technology and a member of our Board of Directors. Prior to joining OmniSeq, Mark spent over twelve years in various executive roles at Thermo Fisher Scientific (previously Life Technologies).
Most recently, Mark was the Vice President and General Manager of the Ion Torrent business unit at Thermo Fisher. Prior to Thermo Fisher, Mark was a Six Sigma Master Black Belt at General Electric, an entrepreneur at two start-up companies, a management consultant at McKinsey and Company, and a Navy Pilot.
Mark is responsible for financing the company, and managing the executive team.
Mark earned an MBA in Finance with Palmer Scholar Distinction from the Wharton School of Business, an MA in National Security Studies from Georgetown University, and a BS with Distinction from the US Naval Academy.